Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML

Targeted immunotherapy in acute myeloid leukemia (AML) is challenged by the lack of AML-specific target antigens and clonal heterogeneity, leading to unwanted on-target off-leukemia toxicity and risk of relapse from minor clones. We hypothesize that combinatorial targeting of AML cells can enhance t...

Descripción completa

Detalles Bibliográficos
Autores principales: Haubner, S., Perna, F., Köhnke, T., Schmidt, C., Berman, S., Augsberger, C., Schnorfeil, F. M., Krupka, C., Lichtenegger, F. S., Liu, X., Kerbs, P., Schneider, S., Metzeler, K. H., Spiekermann, K., Hiddemann, W., Greif, P. A., Herold, T., Sadelain, M., Subklewe, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326956/
https://www.ncbi.nlm.nih.gov/pubmed/29946192
http://dx.doi.org/10.1038/s41375-018-0180-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326956/
https://www.ncbi.nlm.nih.gov/pubmed/29946192
http://dx.doi.org/10.1038/s41375-018-0180-3

Ejemplares similares